Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
May 31, 1986
Study Completion Date
April 30, 2002
Conditions
Graft Versus Host DiseaseLeukemiaLymphoma
Interventions
DRUG
cyclosporine
DRUG
methotrexate
PROCEDURE
allogeneic bone marrow transplantation
Trial Locations (1)
98109
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
lead
Fred Hutchinson Cancer Center
OTHER
NCT00002456 - Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation | Biotech Hunter | Biotech Hunter